Reconfiguring medical diagnostics value chains
By EEN Malta Coordinator, Brigitte Tanti. Featured on The Malta Business Weekly on 14/05/2020
Advances in informatics and engineering have significantly influenced diagnostic and therapeutic options in medicine and the whole health industry is undergoing substantial changes. The advancements in IT and health sectors in the last decade brought a lot of new discoveries, new knowledge and information. Such developments are now evolving significantly into the era of personalised medicine.
The DIGI-B-CUBE project launched an open call for funding last month, to support projects focusing on integrating digital innovations and disruptive technologies across the medical diagnostics and related value chains. SMEs and start-ups operating in the health, medicine, biotech, biopharma, IT or related sectors (robotics, automation, electronics, nanotech, etc.) can apply for equity-free funding, amounting up to €60,000 through the DIGI-B-CUBE voucher scheme.
DIGI-B-CUBE aims to unlock the cross-sectoral collaborative potential of SMEs by combining e.g. Artificial Intelligence (AI), Cognitive Computing Digital Technologies (CCDT) with B-CUBE value chains. B-CUBE is an abbreviation and it stands for Bioimaging, Biosensing and Biobanking:
- Bioimaging, or biological imaging, refers to when creating images of the human body or parts of it to diagnose or examine disease.
- Biosensing is the measurement of a chemical substance, for example glucose monitoring in diabetes patients or other medical health related targets
- Biobanking is the storing of human biological samples so that they can be used for medical research later.
This funding will facilitate the delivery of market sensitive disruptive technologies and will generate innovative solutions that enhance patient-centred diagnostic work-flows. Through directly investing €2.7million in SMEs via voucher-based funding system, DIGI-B-CUBE project aims to support digital innovations and solutions for the reconfiguration of the medical diagnostics and related value chains towards a Health Economy 4.0. Ideally, this funding will support the initiation and propagation of cross-sectoral collaboration that will have long-lasting effects on technology transfer and leads to new innovations, solutions, product or service development.
The various funding streams are as follows:
Receive up to €20,000 per SME and up to €60,000 per project, to prototype or conceptualise a solution for a digitalisation challenge in the medical diagnostics and related value chains. Consortia have to in include at least two SMEs and maximum three organisations from at least two different sectors to be funded.
Customised Solution Innovation Voucher
Receive up to €50,000 per SME and up to €150,000 per project, to jointly develop a novel product/ service based on an existing proven concept that addresses a digitalisation challenge in the Medical Diagnostics and related value chains. Consortia consisting of minimum two SMEs from at least two different sectors will be funded.
Co-working Disruption Lab Voucher
Receive up to €10,000 per SME/project, additional funding to further advance a successfully completed Customised Solution Innovation Voucher project in an incubator / accelerator / co-working space of the DIGI-B-CUBE clusters’ network (or) in labs, technical and innovation facilities of other relevant SMEs. Consortia can include one SME from a completed project consortium and a host organisation.
Get reimbursed for your travel costs (transportation, accommodation and event fees) incurred for attending DIGI-B-CUBE events. Funding is up to €2,000 per voucher and up to €6,000 per SME. Applications must be submitted prior to the event.
SMEs established in one of the EU Member States or H2020 associated countries are eligible to apply for DIGI-B-CUBE vouchers. There are various submission deadlines but the first one is on 29th July 2020. To recap, the sectors of focus include healthcare / medicine / biotech / biopharma, and IT and related sectors (robotics, automation, electronics, nanotech etc).